Top

Published in:

01-11-2017 | Review

Cardiac surgery 2016 reviewed

Authors: Torsten Doenst, Yasin Essa, Khalil Jacoub, Alexandros Moschovas, David Gonzalez-Lopez, Hristo Kirov, Mahmoud Diab, Steffen Bargenda, Gloria Faerber

Published in: Clinical Research in Cardiology | Issue 11/2017

Abstract

For the year 2016, more than 20,000 published references can be found in Pubmed when entering the search term “cardiac surgery”. Publications last year have helped to more clearly delineate the fields where classic surgery and modern interventional techniques overlap. The field of coronary bypass surgery (partially compared to percutaneous coronary intervention) was enriched by five large prospective randomized trials. The value of CABG for complex coronary disease was reconfirmed and for less complex main stem lesions, PCI was found potentially equal. For aortic valve treatment, more evidence was presented for the superiority of transcatheter aortic valve implantation for patients with intermediate risk. However, the 2016 evidence argued against the liberal expansion to the low-risk field, where conventional aortic valve replacement still appears superior. For the mitral valve, many publications emphasized the significant impact of mitral valve reconstruction on survival in structural mitral regurgitation. In addition, there were many relevant and other interesting contributions from the purely operative arena in the fields of coronary revascularization, surgical treatment of valve disease, terminal heart failure (i.e., transplantation and ventricular assist devices), and aortic surgery. While this article attempts to summarize the most pertinent publications it does not have the expectation of being complete and cannot be free of individual interpretation. As in recent years, it provides a condensed summary that is intended to give the reader “solid ground” for up-to-date decision-making in cardiac surgery.

Doenst T, Struning C, Moschovas A, Gonzalez-Lopez D, Valchanov I, Kirov H, Diab M, Faerber G (2015) Cardiac surgery 2014 reviewed. Clin Res Cardiol 104(12):1006–1020. doi:10.1007/s00392-015-0914-4 CrossRefPubMed

Doenst T, Struning C, Moschovas A, Gonzalez-Lopez D, Essa Y, Kirov H, Diab M, Faerber G (2016) Cardiac surgery 2015 reviewed. Clin Res Cardiol 105(10):801–814. doi:10.1007/s00392-016-1013-x CrossRefPubMed

McNeely C, Markwell S, Vassileva C (2016) Trends in patient characteristics and outcomes of coronary artery bypass grafting in the 2000 to 2012 medicare population. Ann Thorac Surg 102(1):132–138. doi:10.1016/j.athoracsur.2016.01.016 CrossRefPubMed

Beckmann A, Funkat AK, Lewandowski J, Frie M, Ernst M, Hekmat K, Schiller W, Gummert JF, Welz A (2016) German Heart Surgery Report 2015: the annual updated Registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 64(6):462–474. doi:10.1055/s-0036-1592124 CrossRefPubMed

Stanetic BM, Ostojic M, Campos CM, Marinkovic J, Farooq V, Kovacevic-Preradovic T, Huber K, Serruys PW (2017) ApPropriateness of myocaRdial RevascularizatiOn assessed by the SYNTAX score II in a coUntry without cardiac Surgery faciliTies; PROUST study. Int J Cardiol 227:478–484. doi:10.1016/j.ijcard.2016.11.001 CrossRefPubMed

Bonzel T, Schachinger V, Dorge H (2016) Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI. Clin Res Cardiol 105(5):388–400. doi:10.1007/s00392-015-0932-2 CrossRefPubMed

Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G, Rouleau JL (2016) Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med 374(16):1511–1520. doi:10.1056/NEJMoa1602001 CrossRefPubMedPubMedCentral

Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogats G, Mansour S, Noiseux N, Sabate M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Page P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP (2016) Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 375(23):2223–2235. doi:10.1056/NEJMoa1610227 CrossRefPubMed

Makikallio T, Holm NR, Lindsay M, Spence MS, Erglis A, Menown IB, Trovik T, Eskola M, Romppanen H, Kellerth T, Ravkilde J, Jensen LO, Kalinauskas G, Linder RB, Pentikainen M, Hervold A, Banning A, Zaman A, Cotton J, Eriksen E, Margus S, Sorensen HT, Nielsen PH, Niemela M, Kervinen K, Lassen JF, Maeng M, Oldroyd K, Berg G, Walsh SJ, Hanratty CG, Kumsars I, Stradins P, Steigen TK, Frobert O, Graham AN, Endresen PC, Corbascio M, Kajander O, Trivedi U, Hartikainen J, Anttila V, Hildick-Smith D, Thuesen L, Christiansen EH (2016) Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet (London, England) 388(10061):2743–2752. doi:10.1016/s0140-6736(16)32052-9 CrossRef

10.

Zheng Z, Xu B, Zhang H, Guan C, Xian Y, Zhao Y, Fan H, Yang Y, Wang W, Gao R, Hu S (2016) Coronary artery bypass graft surgery and percutaneous coronary interventions in patients with unprotected left main coronary artery disease. JACC Cardiovasc Interv 9(11):1102–1111. doi:10.1016/j.jcin.2016.03.039 CrossRefPubMed

11.

Chang M, Lee CW, Ahn JM, Cavalcante R, Sotomi Y, Onuma Y, Zeng Y, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Serruys PW, Park SJ (2016) Coronary artery bypass grafting versus drug-eluting stents implantation for previous myocardial infarction. Am J Cardiol 118(1):17–22. doi:10.1016/j.amjcard.2016.04.009 CrossRefPubMed

12.

Benedetto U, Gaudino M, Ng C, Biondi-Zoccai G, D’Ascenzo F, Frati G, Girardi LN, Angelini GD, Taggart DP (2016) Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials. Int J Cardiol 210:19–24. doi:10.1016/j.ijcard.2016.02.090 CrossRefPubMed

13.

Lamy A, Devereaux PJ, Prabhakaran D, Taggart DP, Hu S, Straka Z, Piegas LS, Avezum A, Akar AR, Lanas Zanetti F, Jain AR, Noiseux N, Padmanabhan C, Bahamondes JC, Novick RJ, Tao L, Olavegogeascoechea PA, Airan B, Sulling TA, Whitlock RP, Ou Y, Gao P, Pettit S, Yusuf S (2016) Five-year outcomes after off-pump or on-pump coronary-artery bypass grafting. N Engl J Med 375(24):2359–2368. doi:10.1056/NEJMoa1601564 CrossRefPubMed

14.

Kirmani BH, Holmes MV, Muir AD (2016) Long-term survival and freedom from reintervention after off-pump coronary artery bypass grafting: a propensity-matched study. Circulation 134(17):1209–1220. doi:10.1161/circulationaha.116.021933 CrossRefPubMed

15.

Pawliszak W, Kowalewski M, Raffa GM, Malvindi PG, Kowalkowska ME, Szwed KA, Borkowska A, Kowalewski J, Anisimowicz L (2016) Cerebrovascular events after no-touch off-pump coronary artery bypass grafting, conventional side-clamp off-pump coronary artery bypass, and proximal anastomotic devices: a meta-analysis. J Am Heart Assoc 5(2):e002802. doi:10.1161/jaha.115.002802 CrossRefPubMedPubMedCentral

16.

Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M (2016) Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med 375(26):2540–2549. doi:10.1056/NEJMoa1610021 CrossRefPubMed

17.

Di Mauro M, Iaco AL, Allam A, Awadi MO, Osman AA, Clemente D, Calafiore AM (2016) Bilateral internal mammary artery grafting: in situ versus Y-graft. Similar 20-year outcome. Eur J Cardiothorac Surg 50(4):729–734. doi:10.1093/ejcts/ezw100 CrossRefPubMed

18.

Magruder JT, Young A, Grimm JC, Conte JV, Shah AS, Mandal K, Sciortino CM, Zehr KJ, Cameron DE, Price J (2016) Bilateral internal thoracic artery grafting: does graft configuration affect outcome? J Thorac Cardiovasc Surg 152(1):120–127. doi:10.1016/j.jtcvs.2016.03.022 CrossRefPubMed

19.

Benedetto U, Gaudino M, Caputo M, Tranbaugh RF, Lau C, Di Franco A, Ng C, Girardi LN, Angelini GD (2016) Right internal thoracic artery versus radial artery as the second best arterial conduit: insights from a meta-analysis of propensity-matched data on long-term survival. J Thorac Cardiovasc Surg 152(4):1083–1091.e1015. doi:10.1016/j.jtcvs.2016.05.022 CrossRefPubMed

20.

Mounsey CA, Mawhinney JA, Werner RS, Taggart DP (2016) Does previous transradial catheterization preclude use of the radial artery as a conduit in coronary artery bypass surgery? Circulation 134(9):681–688. doi:10.1161/circulationaha.116.022992 CrossRefPubMed

21.

Aldea GS, Bakaeen FG, Pal J, Fremes S, Head SJ, Sabik J, Rosengart T, Kappetein AP, Thourani VH, Firestone S, Mitchell JD (2016) The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting. Ann Thorac Surg 101(2):801–809. doi:10.1016/j.athoracsur.2015.09.100 CrossRefPubMed

22.

Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 374(17):1609–1620. doi:10.1056/NEJMoa1514616 CrossRefPubMed

23.

Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, Smalling R, Lim S, Malaisrie SC, Kapadia S, Szeto WY, Greason KL, Kereiakes D, Ailawadi G, Whisenant BK, Devireddy C, Leipsic J, Hahn RT, Pibarot P, Weissman NJ, Jaber WA, Cohen DJ, Suri R, Tuzcu EM, Svensson LG, Webb JG, Moses JW, Mack MJ, Miller DC, Smith CR, Alu MC, Parvataneni R, D’Agostino RB Jr, Leon MB (2016) Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet (London, England) 387(10034):2218–2225. doi:10.1016/s0140-6736(16)30073-3 CrossRef

24.

Schofer J (2016) All over for valve surgery for intermediate-risk patients? Lancet (London, England) 387(10034):2170–2171. doi:10.1016/s0140-6736(16)30122-2 CrossRef

25.

Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, Kleiman NS, Coselli JS, Gleason TG, Lee JS, Hermiller JB Jr, Heiser J, Merhi W, Zorn GL 3rd, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Maini B, Mumtaz M, Conte J, Resar J, Aharonian V, Pfeffer T, Oh JK, Qiao H, Adams DH, Popma JJ (2016) 3-Year outcomes in high-risk patients who underwent surgical or transcatheter aortic valve replacement. J Am Coll Cardiol 67(22):2565–2574. doi:10.1016/j.jacc.2016.03.506 CrossRefPubMed

26.

Sondergaard L, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Ngo AT, Olsen NT, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Olsen PS, Thyregod HG (2016) Two-year outcomes in patients with severe aortic valve stenosis randomized to transcatheter versus surgical aortic valve replacement: the all-comers nordic aortic valve intervention randomized clinical trial. Circ Cardiovasc Interv 9(6):e003665. doi:10.1161/circinterventions.115.003665 CrossRefPubMed

27.

Rosato S, Santini F, Barbanti M, Biancari F, D’Errigo P, Onorati F, Tamburino C, Ranucci M, Covello RD, Santoro G, Grossi C, Ventura M, Fusco D, Seccareccia F (2016) Transcatheter aortic valve implantation compared with surgical aortic valve replacement in low-risk patients. Circ Cardiovasc Interv 9(5):e003326. doi:10.1161/circinterventions.115.003326 CrossRefPubMed

28.

Mollmann H, Bestehorn K, Bestehorn M, Papoutsis K, Fleck E, Ertl G, Kuck KH, Hamm C (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis: complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559. doi:10.1007/s00392-016-0962-4 CrossRefPubMed

29.

Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, Quaini E, Solinas M, Berti S, Glauber M (2016) Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. Eur J Cardiothorac Surg 49(3):960–965. doi:10.1093/ejcts/ezv210 CrossRefPubMed

30.

Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (London, England) 385(9986):2477–2484. doi:10.1016/s0140-6736(15)60308-7 CrossRef

31.

Dvir D, Eltchaninoff H, Ye J, Kan A, Durand E, Bizios A, Cheung A, Aziz M, Simonato M, Tron C, Arbel Y, Moss R, Leipsic J, Ofek H, Perlman G, Barbanti M, Seidman M, Blanke P, Yao R, Boone R, Lauck S, Lichtenstein S, Wood D, Cribier A, Webb J (2016) First look at long-term durability of transcatheter heart valves: Assessment of valve function up to 10-years after implantation. Paper presented at the EuroPCR, Paris

32.

Piccardo A, Blossier JD, Le Guyader A, Orsel I, Sekkal S, Cornu E, Laskar M (2016) Fate of aortic bioprostheses: an 18-year experience. J Thorac Cardiovasc Surg 151(3):754–761.e751. doi:10.1016/j.jtcvs.2015.10.020 CrossRefPubMed

33.

Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, Smedira NG, Svensson LG, Lytle BW, Blackstone EH (2015) Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg 99(4):1239–1247. doi:10.1016/j.athoracsur.2014.10.070 CrossRefPubMedPubMedCentral

34.

Myken PS, Bech-Hansen O (2009) A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 137(1):76–81. doi:10.1016/j.jtcvs.2008.05.068 CrossRefPubMed

35.

Del Trigo M, Munoz-Garcia AJ, Wijeysundera HC, Nombela-Franco L, Cheema AN, Gutierrez E, Serra V, Kefer J, Amat-Santos IJ, Benitez LM, Mewa J, Jimenez-Quevedo P, Alnasser S, Garcia Del Blanco B, Dager A, Abdul-Jawad Altisent O, Puri R, Campelo-Parada F, Dahou A, Paradis JM, Dumont E, Pibarot P, Rodes-Cabau J (2016) Incidence, timing, and predictors of valve hemodynamic deterioration after transcatheter aortic valve replacement: multicenter registry. J Am Coll Cardiol 67(6):644–655. doi:10.1016/j.jacc.2015.10.097 CrossRefPubMed

36.

Borger MA, Dohmen PM, Knosalla C, Hammerschmidt R, Merk DR, Richter M, Doenst T, Conradi L, Treede H, Moustafine V, Holzhey DM, Duhay F, Strauch J (2016) Haemodynamic benefits of rapid deployment aortic valve replacement via a minimally invasive approach: 1-year results of a prospective multicentre randomized controlled trial. Eur J Cardiothorac Surg 50(4):713–720. doi:10.1093/ejcts/ezw042 CrossRefPubMed

37.

Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala M, Madonna F, Meuris B, Haverich A, Shrestha M (2016) Clinical and haemodynamic outcomes in 658 patients receiving the Perceval sutureless aortic valve: early results from a prospective European multicentre study (the Cavalier Trial)dagger. Eur J Cardiothorac Surg 49(3):978–986. doi:10.1093/ejcts/ezv257 CrossRefPubMed

38.

Bowdish ME, Hui DS, Cleveland JD, Mack WJ, Sinha R, Ranjan R, Cohen RG, Baker CJ, Cunningham MJ, Barr ML, Starnes VA (2016) A comparison of aortic valve replacement via an anterior right minithoracotomy with standard sternotomy: a propensity score analysis of 492 patients. Eur J Cardiothorac Surg 49(2):456–463. doi:10.1093/ejcts/ezv038 CrossRefPubMed

39.

Stolinski J, Plicner D, Grudzien G, Wasowicz M, Musial R, Andres J, Kapelak B (2016) A comparison of minimally invasive and standard aortic valve replacement. J Thorac Cardiovasc Surg 152(4):1030–1039. doi:10.1016/j.jtcvs.2016.06.012 CrossRefPubMed

40.

Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR, Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ Jr, Puskas JD, Dagenais F, Burks SG, El-Hamamsy I, Milano CA, Atluri P, Voisine P, O’Gara PT, Gelijns AC (2016) Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 374(20):1932–1941. doi:10.1056/NEJMoa1602003 CrossRefPubMedPubMedCentral

41.

Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA (2016) Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 374(4):344–353. doi:10.1056/NEJMoa1512913 CrossRefPubMed

42.

Nappi F, Spadaccio C, Nenna A, Lusini M, Fraldi M, Acar C, Chello M (2016) Is subvalvular repair worthwhile in severe ischemic mitral regurgitation? Subanalysis of the papillary muscle approximation trial. J Thorac Cardiovasc Surg. doi:10.1016/j.jtcvs.2016.09.050

43.

Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF, de Meester C, Barbieri A, Rusinaru D, Russo A, Pasquet AA, Michelena HI, Huebner M, Maalouf J, Clavel MA, Szymanski C, Enriquez-Sarano ME (2016) Twenty-year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation. Analysis of a large, prospective, multicenter international registry. Circulation. doi:10.1161/circulationaha.116.023340 PubMed

44.

Silaschi M, Chaubey S, Aldalati O, Khan H, Uzzaman MM, Singh M, Baghai M, Deshpande R, Wendler O (2016) Is mitral valve repair superior to mitral valve replacement in elderly patients? Comparison of short- and long-term outcomes in a propensity-matched cohort. J Am Heart Assoc 5(8):e003605. doi:10.1161/jaha.116.003605 CrossRefPubMedPubMedCentral

45.

Coutinho GF, Correia PM, Branco C, Antunes MJ (2016) Long-term results of mitral valve surgery for degenerative anterior leaflet or bileaflet prolapse: analysis of negative factors for repair, early and late failures, and survival. Eur J Cardiothorac Surg 50(1):66–74. doi:10.1093/ejcts/ezv470 CrossRefPubMed

46.

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(23):e521–e643. doi:10.1161/cir.0000000000000031 CrossRefPubMed

47.

Alashi A, Mentias A, Patel K, Gillinov AM, Sabik JF, Popovic ZB, Mihaljevic T, Suri RM, Rodriguez LL, Svensson LG, Griffin BP, Desai MY (2016) Synergistic utility of brain natriuretic peptide and left ventricular global longitudinal strain in asymptomatic patients with significant primary mitral regurgitation and preserved systolic function undergoing mitral valve surgery. Circ Cardiovasc Imaging. doi:10.1161/circimaging.115.004451 PubMed

48.

Clavel MA, Tribouilloy C, Vanoverschelde JL, Pizarro R, Suri RM, Szymanski C, Lazam S, Oberti P, Michelena HI, Jaffe A, Enriquez-Sarano M (2016) Association of B-type natriuretic peptide with survival in patients with degenerative mitral regurgitation. J Am Coll Cardiol 68(12):1297–1307. doi:10.1016/j.jacc.2016.06.047 CrossRefPubMed

49.

Mentias A, Naji P, Gillinov AM, Rodriguez LL, Reed G, Mihaljevic T, Suri RM, Sabik JF, Svensson LG, Grimm RA, Griffin BP, Desai MY (2016) Strain echocardiography and functional capacity in asymptomatic primary mitral regurgitation with preserved ejection fraction. J Am Coll Cardiol 68(18):1974–1986. doi:10.1016/j.jacc.2016.08.030 CrossRefPubMed

50.

Suri RM, Clavel MA, Schaff HV, Michelena HI, Huebner M, Nishimura RA, Enriquez-Sarano M (2016) Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol 67(5):488–498. doi:10.1016/j.jacc.2015.10.098 CrossRefPubMed

51.

Moscarelli M, Fattouch K, Casula R, Speziale G, Lancellotti P, Athanasiou T (2016) What is the role of minimally invasive mitral valve surgery in high-risk patients? A meta-analysis of observational studies. Ann Thorac Surg 101(3):981–989. doi:10.1016/j.athoracsur.2015.08.050 CrossRefPubMed

52.

De Bonis M, Al-Attar N, Antunes M, Borger M, Casselman F, Falk V, Folliguet T, Iung B, Lancellotti P, Lentini S, Maisano F, Messika-Zeitoun D, Muneretto C, Pibarot P, Pierard L, Punjabi P, Rosenhek R, Suwalski P, Vahanian A, Wendler O, Prendergast B (2016) Surgical and interventional management of mitral valve regurgitation: a position statement from the European Society of Cardiology Working Groups on Cardiovascular Surgery and Valvular Heart Disease. Eur Heart J 37(2):133–139. doi:10.1093/eurheartj/ehv322 CrossRefPubMed

53.

Takagi H, Ando T, Umemoto T (2016) A review of comparative studies of MitraClip versus surgical repair for mitral regurgitation. Int J Cardiol 228:289–294. doi:10.1016/j.ijcard.2016.11.153 CrossRefPubMed

54.

De Bonis M, Lapenna E, Buzzatti N, La Canna G, Denti P, Pappalardo F, Schiavi D, Pozzoli A, Cioni M, Di Giannuario G, Alfieri O (2016) Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years? Eur J Cardiothorac Surg 50(3):488–494. doi:10.1093/ejcts/ezw093 CrossRefPubMed

55.

Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L (2015) Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66(25):2844–2854. doi:10.1016/j.jacc.2015.10.018 CrossRefPubMed

56.

Schwencke C, Bijuklic K, Ouarrak T, Lubos E, Schillinger W, Plicht B, Eggebrecht H, Baldus S, Schymik G, Boekstegers P, Hoffmann R, Senges J, Schofer J (2017) Impact of cardiac comorbidities on early and 1-year outcome after percutaneous mitral valve interventions: data from the German transcatheter mitral valve interventions (TRAMI) registry. Clin Res Cardiol 106(4):249–258. doi:10.1007/s00392-016-1044-3 CrossRefPubMed

57.

Wallenborn J, Stork S, Herrmann S, Kukuy O, Fette G, Puppe F, Gorski A, Hu K, Voelker W, Ertl G, Weidemann F (2016) Prevalence of severe mitral regurgitation eligible for edge-to-edge mitral valve repair (MitraClip). Clin Res Cardiol 105(8):699–709. doi:10.1007/s00392-016-0975-z CrossRefPubMed

58.

Badhwar V, Rankin JS, He M, Jacobs JP, Furnary AP, Fazzalari FL, O’Brien S, Gammie JS, Shahian DM (2016) Performing concomitant tricuspid valve repair at the time of mitral valve operations is not associated with increased operative mortality. Ann Thorac Surg. doi:10.1016/j.athoracsur.2016.06.004

59.

Gosev I, Yammine M, McGurk S, Ejiofor JI, Norman A, Ivkovic V, Cohn LH (2016) Should moderate-to-severe tricuspid regurgitation be repaired during reoperative left-sided valve procedures? Semin Thorac Cardiovasc Surg 28(1):38–45. doi:10.1053/j.semtcvs.2015.11.004 CrossRefPubMed

60.

Han J, Takeda K, Takayama H, Kurlansky PA, Mauro CM, Colombo PC, Yuzefpolskaya M, Fukuhara S, Truby LK, Topkara VK, Garan AR, Mancini DM, Naka Y (2016) Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. J Thorac Cardiovasc Surg 151(2):520–527.e521. doi:10.1016/j.jtcvs.2015.09.082 CrossRefPubMed

61.

Song HK, Gelow JM, Mudd J, Chien C, Tibayan FA, Hollifield K, Naftel D, Kirklin J (2016) Limited utility of tricuspid valve repair at the time of left ventricular assist device implantation. Ann Thorac Surg 101(6):2168–2174. doi:10.1016/j.athoracsur.2016.03.040 CrossRefPubMedPubMedCentral

62.

Anselmi A, Ruggieri VG, Harmouche M, Flecher E, Corbineau H, Langanay T, Lelong B, Verhoye JP, Leguerrier A (2016) Appraisal of long-term outcomes of tricuspid valve replacement in the current perspective. Ann Thorac Surg 101(3):863–871. doi:10.1016/j.athoracsur.2015.09.081 CrossRefPubMed

63.

Liu P, Qiao WH, Sun FQ, Ruan XL, Al Shirbini M, Hu D, Chen S, Dong NG (2016) Should a mechanical or biological prosthesis be used for a tricuspid valve replacement? A meta-analysis. J Cardiac Surg 31(5):294–302. doi:10.1111/jocs.12730 CrossRef

64.

Poon SS, Theologou T, Harrington D, Kuduvalli M, Oo A, Field M (2016) Hemiarch versus total aortic arch replacement in acute type A dissection: a systematic review and meta-analysis. Ann Cardiothorac Surg 5(3):156–173. doi:10.21037/acs.2016.05.06 CrossRefPubMedPubMedCentral

65.

Yan Y, Xu L, Zhang H, Xu ZY, Ding XY, Wang SW, Xue X, Tan MW (2016) Proximal aortic repair versus extensive aortic repair in the treatment of acute type A aortic dissection: a meta-analysis. Eur J Cardiothorac Surg 49(5):1392–1401. doi:10.1093/ejcts/ezv351 CrossRefPubMed

66.

Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, Hughes GC (2014) Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. J Am Coll Cardiol 63(17):1796–1803. doi:10.1016/j.jacc.2013.10.085 CrossRefPubMedPubMedCentral

67.

Chiu P, Miller DC (2016) Evolution of surgical therapy for Stanford acute type A aortic dissection. Ann Cardiothorac Surg 5(4):275–295. doi:10.21037/acs.2016.05.05 CrossRefPubMedPubMedCentral

68.

Andersen ND, Benrashid E, Ross AK, Pickett LC, Smith PK, Daneshmand MA, Schroder JN, Gaca JG, Hughes GC (2016) The utility of the aortic dissection team: outcomes and insights after a decade of experience. Ann Cardiothorac Surg 5(3):194–201. doi:10.21037/acs.2016.05.12 CrossRefPubMedPubMedCentral

69.

Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, Walsh MN, Milano CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C (2016) A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. doi:10.1056/NEJMoa1610426 PubMed

70.

Zafar F, Villa CR, Morales DL, Blume ED, Rosenthal DN, Kirklin JK, Lorts A (2016) Does small size matter with continuous flow devices? Analysis of the INTERMACS database of adults with BSA ≤1.5 m². JACC Heart. doi:10.1016/j.jchf.2016.09.009

71.

Clerkin KJ, Naka Y, Mancini DM, Colombo PC, Topkara VK (2016) The impact of obesity on patients bridged to transplantation with continuous-flow left ventricular assist devices. JACC Heart Fail 4(10):761–768. doi:10.1016/j.jchf.2016.05.010 CrossRefPubMed

72.

Acharya D, Loyaga-Rendon RY, Pamboukian SV, Tallaj JA, Holman WL, Cantor RS, Naftel DC, Kirklin JK (2016) Ventricular assist device in acute myocardial infarction. J Am Coll Cardiol 67(16):1871–1880. doi:10.1016/j.jacc.2016.02.025 CrossRefPubMed

73.

Madan S, Saeed O, Shin J, Sims D, Goldstein D, Pina I, Jorde U, Patel SR (2016) Donor troponin and survival after cardiac transplantation: an analysis of the united network of organ sharing registry. Circ Heart Fail. doi:10.1161/circheartfailure.115.002909

74.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129–2200. doi:10.1093/eurheartj/ehw128 CrossRefPubMed

Title: Cardiac surgery 2016 reviewed
Authors: Torsten Doenst
Yasin Essa
Khalil Jacoub
Alexandros Moschovas
David Gonzalez-Lopez
Hristo Kirov
Mahmoud Diab
Steffen Bargenda
Gloria Faerber
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Research in Cardiology / Issue 11/2017
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-017-1113-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cardiac surgery 2016 reviewed

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2017

Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue

Epidemiology of heart failure in Germany: a retrospective database study

Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction

Coronary air embolism in a trauma patient

Declining radiation dose of coronary computed tomography angiography: German cardiac CT registry experience 2009–2014

Treatment of chronic heart failure in Germany: a retrospective database study